|
US113452A
(en)
*
|
|
1871-04-04 |
|
Improvement in table-leaf supports |
|
US166159A
(en)
*
|
|
1875-07-27 |
|
Improvement in calcining-kilns |
|
US77276A
(en)
*
|
|
1868-04-28 |
|
Improvement in spring and body braces for vehicles |
|
US3845217A
(en)
*
|
1972-11-16 |
1974-10-29 |
Helsingborg L Ab |
Buffered smoking substitute compositions
|
|
US4321387A
(en)
|
1980-03-21 |
1982-03-23 |
Philip Morris, Incorporated |
Process for the preparation of optically active nicotine analogs
|
|
US4442292A
(en)
|
1981-01-29 |
1984-04-10 |
Philip Morris Incorporated |
Optically active nicotine analogs and process for their preparation
|
|
US4332945A
(en)
|
1981-01-29 |
1982-06-01 |
Philip Morris, Incorporated |
Optically active nicotine analogs and process for their preparation
|
|
US4590278A
(en)
|
1981-01-29 |
1986-05-20 |
Philip Morris Incorporated |
Nicotine analogs
|
|
US4452984A
(en)
|
1981-01-29 |
1984-06-05 |
Philip Morris, Inc. |
Optically active nicotine analogs and process for their preparation
|
|
GB8301659D0
(en)
*
|
1983-01-21 |
1983-02-23 |
Leo Ab |
Smoking substitutes
|
|
GB8317576D0
(en)
*
|
1983-06-29 |
1983-08-03 |
Shaw A S W |
Consumer tobacco products
|
|
US4953572A
(en)
*
|
1985-04-25 |
1990-09-04 |
Rose Jed E |
Method and apparatus for aiding in the reduction of incidence of tobacco smoking
|
|
US4920989A
(en)
*
|
1985-04-25 |
1990-05-01 |
Regents Of The University Of California |
Method and apparatus for aiding in the reduction of incidence of tobacco smoking
|
|
US5023252A
(en)
|
1985-12-04 |
1991-06-11 |
Conrex Pharmaceutical Corporation |
Transdermal and trans-membrane delivery of drugs
|
|
DE3639418A1
(de)
*
|
1986-11-18 |
1988-06-09 |
Forschungsgesellschaft Rauchen |
Nikotinhaltiges mittel
|
|
US5001139A
(en)
|
1987-06-12 |
1991-03-19 |
American Cyanamid Company |
Enchancers for the transdermal flux of nivadipine
|
|
US4992445A
(en)
|
1987-06-12 |
1991-02-12 |
American Cyanamid Co. |
Transdermal delivery of pharmaceuticals
|
|
US5073380A
(en)
|
1987-07-27 |
1991-12-17 |
Mcneil-Ppc, Inc. |
Oral sustained release pharmaceutical formulation and process
|
|
ATE122353T1
(de)
|
1987-10-05 |
1995-05-15 |
Yamanouchi Pharma Co Ltd |
Heterozyklische spiroverbindungen und ihre herstellung.
|
|
IE62662B1
(en)
*
|
1989-01-06 |
1995-02-22 |
Elan Corp Plc |
Use of nicotine in the treatment of conditions susceptible to said treatment
|
|
US5525351A
(en)
*
|
1989-11-07 |
1996-06-11 |
Dam; Anders |
Nicotine containing stimulant unit
|
|
US5512306A
(en)
*
|
1992-06-19 |
1996-04-30 |
Pharmica Ab |
Smoking substitute
|
|
DK0588917T3
(da)
|
1991-05-29 |
2001-02-12 |
Abbott Lab |
Isoxazol- og isothiazolforbindelser, som forstærker kognitiv funktion
|
|
GB9200047D0
(en)
*
|
1992-01-03 |
1992-02-26 |
Univ Alberta |
Nicotine-containing nasal spray
|
|
US5212188A
(en)
*
|
1992-03-02 |
1993-05-18 |
R. J. Reynolds Tabacco Company |
Method for treatment of neurodegenerative diseases
|
|
US5242934A
(en)
*
|
1992-03-02 |
1993-09-07 |
R. J. Reynolds Tobacco Company |
Method for treatment of neurodegenerative diseases
|
|
US5227391A
(en)
*
|
1992-04-10 |
1993-07-13 |
R. J. Reynolds Tobacco Company |
Method for treatment of neurodegenerative diseases
|
|
US5232933A
(en)
*
|
1992-05-21 |
1993-08-03 |
R. J. Reynolds Tobacco Company |
Method for treatment of neurodegenerative diseases
|
|
US5248690A
(en)
*
|
1992-07-07 |
1993-09-28 |
R. J. Reynolds Tobacco Company |
Method for treatment of neurodegenerative diseases
|
|
IL107184A
(en)
|
1992-10-09 |
1997-08-14 |
Abbott Lab |
Heterocyclic ether compounds that enhance cognitive function
|
|
US5549906A
(en)
*
|
1993-07-26 |
1996-08-27 |
Pharmacia Ab |
Nicotine lozenge and therapeutic method for smoking cessation
|
|
US6121276A
(en)
|
1994-04-22 |
2000-09-19 |
Pentech Pharmaceuticals, Inc. |
Apomorphine-containing dosage forms for ameliorating male erectile dysfunction
|
|
US5703100A
(en)
|
1994-11-10 |
1997-12-30 |
Sibia Neurosciences, Inc. |
Modulators of acetylcholine receptors
|
|
IL118279A
(en)
|
1995-06-07 |
2006-10-05 |
Abbott Lab |
Compounds 3 - Pyridyloxy (or Thio) Alkyl Heterocyclic Pharmaceutical Compositions Containing Them and Their Uses for Preparing Drugs to Control Synaptic Chemical Transmission
|
|
WO1997011073A1
(en)
|
1995-09-22 |
1997-03-27 |
Novo Nordisk A/S |
Novel substituted azacyclic or azabicyclic compounds
|
|
JPH11512443A
(ja)
|
1995-09-22 |
1999-10-26 |
ノボ ノルディスク アクティーゼルスカブ |
新規な置換アザ環式またはアザ二環式化合物
|
|
ES2197255T3
(es)
|
1995-11-17 |
2004-01-01 |
MERCK & CO. INC. |
Nuevos compuestos de arilo sustituido utiles como moduladores de los receptores de acetilcolina.
|
|
AU2340397A
(en)
|
1996-03-21 |
1997-10-10 |
Mayo Foundation For Medical Education And Research |
Use of nicotine to treat liver disease
|
|
US5629325A
(en)
|
1996-06-06 |
1997-05-13 |
Abbott Laboratories |
3-pyridyloxymethyl heterocyclic ether compounds useful in controlling chemical synaptic transmission
|
|
GB9614902D0
(en)
*
|
1996-07-16 |
1996-09-04 |
Rhodes John |
Sustained release composition
|
|
US6020335A
(en)
|
1997-02-06 |
2000-02-01 |
Pfizer Inc |
(N-(pyridinylmethyl)-heterocyclic)ylideneamine compounds as nicotinic acetylcholine receptor binding agents
|
|
US5861423A
(en)
*
|
1997-02-21 |
1999-01-19 |
Caldwell; William Scott |
Pharmaceutical compositions incorporating aryl substituted olefinic amine compounds
|
|
PL335619A1
(en)
|
1997-03-11 |
2000-05-08 |
Darwin Discovery Ltd |
Dosage forms including separate parts containing r and s enantiomers
|
|
FR2761072B1
(fr)
|
1997-03-20 |
1999-04-23 |
Synthelabo |
Derives de 2,3-dihydrofuro[3,2-b]pyridine, leur preparation et leur application en therapeutique
|
|
US5977131A
(en)
|
1997-04-09 |
1999-11-02 |
Pfizer Inc. |
Azaindole-ethylamine derivatives as nicotinic acetylcholine receptor binding agents
|
|
US6024981A
(en)
|
1997-04-16 |
2000-02-15 |
Cima Labs Inc. |
Rapidly dissolving robust dosage form
|
|
DK0984966T3
(da)
|
1997-05-30 |
2003-05-05 |
Neurosearch As |
9-azabicyclo[3.3.1]non-2-en derivater, som er cholinerge ligander på nikotin-ACh receptorer
|
|
NZ500643A
(en)
|
1997-05-30 |
2001-12-21 |
Neurosearch As |
Spiro-quinuclidine derivatives and their use in treating conditions responsive to nicotinic ACh receptor modulators
|
|
CA2289576A1
(en)
|
1997-05-30 |
1998-12-03 |
Neurosearch A/S |
Azacyclooctane and heptane derivatives, their preparation and use in therapy
|
|
CA2289574C
(en)
|
1997-05-30 |
2007-04-24 |
Neurosearch A/S |
8-azabicyclo(3,2,1)oct-2-ene and octane derivatives as cholinergic ligands at nicotinic ach receptors
|
|
FR2765874B1
(fr)
|
1997-07-09 |
1999-08-13 |
Synthelabo |
Derives de 6-pyrrolidin-2-ylpyrindines, leur preparation et leur application en therapeutique
|
|
AR013184A1
(es)
|
1997-07-18 |
2000-12-13 |
Astrazeneca Ab |
Aminas heterociclicas espiroazobiciclicas, composicion farmaceutica, uso de dichas aminas para preparar medicamentos y metodo de tratamiento o profilaxis
|
|
US6034079A
(en)
*
|
1997-08-11 |
2000-03-07 |
University Of South Florida |
Nicotine antagonists for nicotine-responsive neuropsychiatric disorders
|
|
AU744539B2
(en)
|
1997-10-27 |
2002-02-28 |
Neurosearch A/S |
Heteroaryl diazacycloalkanes as cholinergic ligands at nicotinic acetylcholine receptors
|
|
CA2306477A1
(en)
|
1997-11-05 |
1999-05-20 |
Neurosearch A/S |
Azaring-ether derivatives and their use as nicotinic ach receptor modulators
|
|
US6057446A
(en)
*
|
1998-04-02 |
2000-05-02 |
Crooks; Peter Anthony |
Certain 1-aza-tricyclo [3.3.1-13,7 ] decane compounds
|
|
EP0955301A3
(en)
|
1998-04-27 |
2001-04-18 |
Pfizer Products Inc. |
7-aza-bicyclo[2.2.1]-heptane derivatives, their preparation and use according to their affinity for neuronal nicotinic acetylcholine receptors
|
|
US6211194B1
(en)
*
|
1998-04-30 |
2001-04-03 |
Duke University |
Solution containing nicotine
|
|
US6232316B1
(en)
*
|
1998-06-16 |
2001-05-15 |
Targacept, Inc. |
Methods for treatment of CNS disorders
|
|
US6365182B1
(en)
|
1998-08-12 |
2002-04-02 |
Cima Labs Inc. |
Organoleptically pleasant in-mouth rapidly disintegrable potassium chloride tablet
|
|
US6368625B1
(en)
|
1998-08-12 |
2002-04-09 |
Cima Labs Inc. |
Orally disintegrable tablet forming a viscous slurry
|
|
CA2341989A1
(en)
|
1998-08-25 |
2000-03-02 |
Ortho-Mcneil Pharmaceutical, Inc. |
Pyridyl ethers and thioethers as ligands for nicotinic acetylcholine receptor and its therapeutic application
|
|
US6262124B1
(en)
*
|
1998-10-22 |
2001-07-17 |
Gary Maurice Dull |
Pharmaceutical compositions and methods for use
|
|
NZ510287A
(en)
|
1998-11-27 |
2003-05-30 |
Neurosearch As |
8-azabicyclo[3.2.1]oct-2-ene and -octane derivatives useful as cholinergic ligands at the nicotinic acetyl choline receptor
|
|
FR2786770B1
(fr)
|
1998-12-04 |
2001-01-19 |
Synthelabo |
Derives de 1,4-diazabicyclo[3.2.2.]nonane, leur preparation et leur application en therapeutique
|
|
FR2786769B1
(fr)
|
1998-12-04 |
2002-10-25 |
Synthelabo |
Derives de 2,5-diazabicyclo[2.2.1]heptane, leur preparation et leur application en therapeutique
|
|
AU2368600A
(en)
*
|
1998-12-16 |
2000-07-03 |
University Of South Florida |
Exo-s-mecamylamine formulation and use in treatment
|
|
EP1147112B1
(en)
|
1999-01-29 |
2003-10-29 |
Abbott Laboratories |
Diazabicyclic derivatives as nicotinic acetylcholine receptor ligands
|
|
US6583160B2
(en)
*
|
1999-04-14 |
2003-06-24 |
Steve Smith |
Nicotine therapy method and oral carrier for assuaging tobacco-addiction
|
|
WO2000064885A1
(en)
|
1999-04-26 |
2000-11-02 |
Neurosearch A/S |
Heteroaryl diazacycloalkanes, their preparation and use
|
|
NZ513575A
(en)
|
1999-05-04 |
2003-07-25 |
Neurosearch As |
Heteroaryl diazabicycloalkanes useful for treating or preventing a disease or a disorder responsive to the activity of nAChR modulators
|
|
US20040229908A1
(en)
|
1999-07-13 |
2004-11-18 |
Jodi Nelson |
Compositions and methods for the treatment of Parkinson's disease and tardive dyskinesias
|
|
US20080138399A1
(en)
*
|
1999-07-16 |
2008-06-12 |
Aradigm Corporation |
Dual release nicotine formulations, and systems and methods for their use
|
|
US6799576B2
(en)
*
|
1999-07-16 |
2004-10-05 |
Aradigm Corporation |
System for effecting smoking cessation
|
|
US8256433B2
(en)
*
|
1999-07-16 |
2012-09-04 |
Aradigm Corporation |
Systems and methods for effecting cessation of tobacco use
|
|
US20080138398A1
(en)
*
|
1999-07-16 |
2008-06-12 |
Aradigm Corporation |
Dual release nicotine formulations, and systems and methods for their use
|
|
US20080138294A1
(en)
*
|
1999-07-16 |
2008-06-12 |
Igor Gonda |
Systems and methods for effecting cessation of tobacco use
|
|
US8188043B2
(en)
*
|
1999-07-28 |
2012-05-29 |
The Board Of Trustees Of The Leland Stanford Jr. University |
Nicotine in therapeutic angiogenesis and vasculogenesis
|
|
FR2798065B1
(fr)
*
|
1999-09-02 |
2003-09-05 |
Assist Publ Hopitaux De Paris |
Utilisation de la nicotine ou de ses derives dans un medicament pour le traitement des maladies neurologiques, notamment la maladie de parkinson
|
|
SE9903998D0
(sv)
*
|
1999-11-03 |
1999-11-03 |
Astra Ab |
New compounds
|
|
JP2001261652A
(ja)
*
|
2000-03-21 |
2001-09-26 |
Suntory Ltd |
二置換イミノヘテロサイクリック化合物
|
|
US6489025B2
(en)
*
|
2000-04-12 |
2002-12-03 |
Showa Denko K.K. |
Fine carbon fiber, method for producing the same and electrically conducting material comprising the fine carbon fiber
|
|
US6955821B2
(en)
|
2000-04-28 |
2005-10-18 |
Adams Laboratories, Inc. |
Sustained release formulations of guaifenesin and additional drug ingredients
|
|
AU2001279284A1
(en)
|
2000-07-05 |
2002-01-14 |
Capricorn Pharma, Inc |
Rapid-melt semi-solid compositions, methods of making same and methods of using same
|
|
GB0022084D0
(en)
*
|
2000-09-08 |
2000-10-25 |
Univ Aberdeen |
Treatment of multiply antibiotic-resistant organisms
|
|
WO2002030392A2
(en)
|
2000-10-12 |
2002-04-18 |
Beecham Pharmaceuticals (Pte) Limited |
Formulation containing amoxicillin
|
|
CN1553771A
(zh)
|
2001-03-26 |
2004-12-08 |
史密丝克莱恩比彻姆公司 |
含烟碱的口服剂量形式
|
|
SE0102197D0
(sv)
*
|
2001-06-20 |
2001-06-20 |
Pharmacia Ab |
New product and use and manufacture thereof
|
|
SE0103211D0
(sv)
|
2001-09-27 |
2001-09-27 |
Pharmacia Ab |
New formulations and use thereof
|
|
US20030119879A1
(en)
*
|
2001-10-15 |
2003-06-26 |
Thomas Landh |
Nicotine and chocolate compositions
|
|
US20030087937A1
(en)
*
|
2001-10-15 |
2003-05-08 |
Nils-Olof Lindberg |
Nicotine and cocoa powder compositions
|
|
US20040037879A1
(en)
*
|
2001-11-02 |
2004-02-26 |
Adusumilli Prasad S. |
Oral controlled release forms useful for reducing or preventing nicotine cravings
|
|
US8329217B2
(en)
|
2001-11-06 |
2012-12-11 |
Osmotica Kereskedelmi Es Szolgaltato Kft |
Dual controlled release dosage form
|
|
US20040052843A1
(en)
*
|
2001-12-24 |
2004-03-18 |
Lerner E. Itzhak |
Controlled release dosage forms
|
|
SE0104388D0
(sv)
|
2001-12-27 |
2001-12-27 |
Pharmacia Ab |
New formulation and use and manufacture thereof
|
|
US6852741B2
(en)
*
|
2001-12-31 |
2005-02-08 |
University Of Florida |
Compositions and methods for treatment of neurological disorders
|
|
CA2473536A1
(en)
|
2002-01-16 |
2003-07-31 |
Endo Pharmaceuticals, Inc. |
Pharmaceutical composition and method for treating disorders of the central nervous system
|
|
US20030159702A1
(en)
*
|
2002-01-21 |
2003-08-28 |
Lindell Katarina E.A. |
Formulation and use manufacture thereof
|
|
US20040166159A1
(en)
*
|
2002-05-29 |
2004-08-26 |
Chien-Hsuan Han |
Pharmaceutical dosage forms having immediate and controlled release properties that contain an aromatic amino acid decarboxylase inhibitor and levodopa
|
|
US7767698B2
(en)
*
|
2002-06-03 |
2010-08-03 |
Mcneil Ab |
Formulation and use thereof
|
|
WO2003105809A1
(en)
|
2002-06-17 |
2003-12-24 |
Themis Laboratories Private Limited |
Multilayer tablets containing thiazolidinedione and biguanides and methods for producing them
|
|
US20040052851A1
(en)
*
|
2002-09-16 |
2004-03-18 |
Graff Allan H. |
Modified release oral dosage form
|
|
DK1803443T3
(en)
*
|
2002-12-20 |
2019-02-25 |
Niconovum Ab |
Nicotine-containing particulate material with a crystalline cellulose
|
|
SE0301320D0
(sv)
*
|
2003-05-06 |
2003-05-06 |
Astrazeneca Ab |
Positive modulators of nicotinic acetylcholine receptors
|
|
WO2004103283A2
(en)
*
|
2003-05-14 |
2004-12-02 |
Pharmacia Corporation |
Compositions of a cyclooxygenase-2 selective inhibitor and a central nervous system stimulant for the treatment of central nervous system damage
|
|
US7149574B2
(en)
*
|
2003-06-09 |
2006-12-12 |
Palo Alto Investors |
Treatment of conditions through electrical modulation of the autonomic nervous system
|
|
DE10338174A1
(de)
|
2003-08-20 |
2005-03-24 |
Lts Lohmann Therapie-Systeme Ag |
Transdermale Arzneimittelzubereitungen mit Wirkstoffkombinationen zur Behandlung der Parkinson-Krankheit
|
|
US7282217B1
(en)
|
2003-08-29 |
2007-10-16 |
Kv Pharmaceutical Company |
Rapidly disintegrable tablets
|
|
ES2321721T3
(es)
*
|
2003-09-08 |
2009-06-10 |
Mcneil Ab |
Formulaciones de nicotina y uso de las mismas.
|
|
US20050113452A1
(en)
*
|
2003-10-20 |
2005-05-26 |
Moshe Flashner-Barak |
Composition and dosage form for sustained effect of levodopa
|
|
US20050266032A1
(en)
|
2003-12-17 |
2005-12-01 |
Sovereign Pharmaceuticals, Ltd. |
Dosage form containing multiple drugs
|
|
CN1332667C
(zh)
*
|
2004-05-26 |
2007-08-22 |
中国科学院生物物理研究所 |
一种抗帕金森症（pd）复合制剂
|
|
BRPI0517494A
(pt)
|
2004-12-22 |
2008-10-14 |
Memory Pharm Corp |
composto, composição farmacêutica, método de ativação/estimulação seletiva de receptores nicotìnicos de a-7 em um paciente em que tal ativação/estimulação tem um efeito terapêutico, método de tratamento de um paciente que sofre de uma doença psicótica, uma doença neurodegenerativa que envolve uma disfunção do sistema colinérgico, e/ou uma condição de debilitação da memória e/ou da cognição, método de tratamento de um paciente que sofre de demência e/ou uma outra condição com perda da memória, método de tratamento de um paciente que sofre de debilitação da memória devido à debilitação cognitiva suave devido ao envelhecimento, mal de alzheimer, esquizofrenia, mal de parkinson, mal de huntington, mal de pick, mal de creutzfeldt-jakob, depressão, envelhecimento, trauma na cabeça, acidente vascular cerebral, hipoxia do snc, senilidade cerebral, demência de multiinfarto, hiv e/ou doença cardiovascular, método de tratamento e/ou prevenção da demência em um paciente com o mal de alzheimer, método de tratamento de um paciente para cortar o vìcio do álcool ou o tratamento de um paciente com a terapia anti-intoxicação, método de tratamento de um paciente para propiciar neuroproteção contra os danos associados com acidentes vasculares cerebrais e isquemia e excitotoxicidade induzida por glutamatos, método de tratamento de um paciente que sofre do vìcio da nicotina, dor, tontura do fuso horário, obesidade e/ou diabetes, método de indução do ato de parar fumar em um paciente, método de tratamento de um paciente que sofre de debilitação cognitiva suave (mci), demência vascular (vad), declìnio cognitivo associado com a idade (aacd), amnésia associada com a cirurgia com o coração aberto, parada cardìaca, anestesia geral, deficiências da memória devido à exposição a agentes anestésicos, debilitação cognitiva induzida pela privação do sono, sìndrome de fadiga crÈnica, narcolepsia, demência relacionada com a aids, debilitação cognitiva relacionada com a epilepsia, sìndrome de down, demência relacionada ao alcoolismo, debilitações da memória induzidas por drogas/substáncias, demência pugilìstica (sìndrome do boxeador), ou demência animal, método para o tratamento da perda da memória, método para o tratamento de um paciente que sofre de debilitação da memória, método para o tratamento ou a profilaxia de uma doença ou de uma condição resultante da disfunção da transmissão do receptor nicotìnico de acetilcolina em um paciente, método para o tratamento ou a profilaxia de uma doença ou de uma condição resultante de receptores nicotìnicos de acetilcolina defeituosos ou funcionando mal em um paciente, método para o tratamento ou a profilaxia de uma doença ou de uma condição resultante da transmissão suprimida do receptor nicotìnico de acetilcolina em um paciente, método para o tratamento ou a profilaxia de uma doença ou de uma condição resultante da perda de sinapses colinérgicas em um paciente, método para a proteção dos neurÈnios em um paciente com neurotoxicidade induzi
|
|
CN101299992A
(zh)
|
2005-11-04 |
2008-11-05 |
伊士曼化工公司 |
药物活性物质长效输送用羧烷基纤维素酯
|
|
US7958887B2
(en)
*
|
2006-03-10 |
2011-06-14 |
Aradigm Corporation |
Nozzle pore configuration for intrapulmonary delivery of aerosolized formulations
|
|
JP2009529561A
(ja)
|
2006-03-16 |
2009-08-20 |
ニコノヴァム エービー |
ニコチンの速やかな放出をもたらす安定なロゼンジ組成物
|
|
US20070269492A1
(en)
*
|
2006-05-16 |
2007-11-22 |
Per Steen |
New product and use and manufacture thereof
|
|
ES2521494T3
(es)
*
|
2007-04-02 |
2014-11-12 |
Parkinson's Institute |
Métodos y composiciones para la reducción de los efectos secundarios de tratamientos terapéuticos
|